Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells.
Che PP, Gregori A, Bergonzini C, Ali M, Mantini G, Schmidt T, Finamore F, Rodrigues SMF, Frampton AE, McDonnell LA, Danen EH, Slotman BJ, Sminia P, Giovannetti E. Che PP, et al. Among authors: bergonzini c. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1328-1343. doi: 10.1016/j.ijrobp.2023.10.035. Epub 2023 Oct 31. Int J Radiat Oncol Biol Phys. 2024. PMID: 37914140
Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC).
Gregori A, Bergonzini C, Capula M, Mantini G, Khojasteh-Leylakoohi F, Comandatore A, Khalili-Tanha G, Khooei A, Morelli L, Avan A, Danen EH, Schmidt T, Giovannetti E. Gregori A, et al. Among authors: bergonzini c. Cancers (Basel). 2023 Jan 19;15(3):628. doi: 10.3390/cancers15030628. Cancers (Basel). 2023. PMID: 36765586 Free PMC article.
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells.
Bergonzini C, Gregori A, Hagens TMS, van der Noord VE, van de Water B, Zweemer AJM, Coban B, Capula M, Mantini G, Botto A, Finamore F, Garajova I, McDonnell LA, Schmidt T, Giovannetti E, Danen EHJ. Bergonzini C, et al. J Exp Clin Cancer Res. 2024 Jan 2;43(1):4. doi: 10.1186/s13046-023-02879-8. J Exp Clin Cancer Res. 2024. PMID: 38163893 Free PMC article.
Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.
Cascioferro S, Petri GL, Parrino B, Carbone D, Funel N, Bergonzini C, Mantini G, Dekker H, Geerke D, Peters GJ, Cirrincione G, Giovannetti E, Diana P. Cascioferro S, et al. Among authors: bergonzini c. Eur J Med Chem. 2020 Mar 1;189:112088. doi: 10.1016/j.ejmech.2020.112088. Epub 2020 Jan 25. Eur J Med Chem. 2020. PMID: 32007666